![James Parsons](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Parsons
Presidente presso
DIAMEDICA THERAPEUTICS INC.
Patrimonio netto: 577 743 $ in data 31/05/2026
Profilo
Mr. James T.
Parsons, CPA, is a Chief Financial Officer & Director at Sernova Biotherapeutics, Inc. and a Chairman at DiaMedica Therapeutics, Inc. He is on the Board of Directors at Oncolytics Biotech, Inc. and Sernova Biotherapeutics, Inc. Mr. Parsons was previously employed as a Chief Financial & Accounting Officer by Trillium Therapeutics, Inc., a Chief Financial Officer by Amorfix Life Sciences Ltd., a Chief Financial Officer & Secretary by Trillium Therapeutics, Inc. /Old/, a Vice President-Finance & Administration by Lorus Therapeutics, Inc., and a Controller & Assistant Treasurer by Timminco Ltd. He also served on the board at YM BioSciences, Inc. He received his graduate degree from The University of Waterloo.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/06/2026 | 75.854 ( -.--% ) | 454 365 $ | 31/05/2026 | |
| 14/04/2026 | 614.605 ( 0,18% ) | 66 377 $ | 31/05/2026 | |
| 01/06/2026 | 41.849 ( 0,04% ) | 43 523 $ | 31/05/2026 | |
| 01/06/2026 | 2.250 ( 0% ) | 13 478 $ | 31/05/2026 |
Posizioni attive di James Parsons
| Società | Posizione | Inizio |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Presidente | 01/01/2025 |
| SERNOVA BIOTHERAPEUTICS INC | Direttore Finanziario/CFO | 11/10/2024 |
| ONCOLYTICS BIOTECH INC. | Direttore/Membro del Consiglio | 16/06/2022 |
Precedenti posizioni note di James Parsons
| Società | Posizione | Fine |
|---|---|---|
| TRILLIUM THERAPEUTICS | Direttore Finanziario/CFO | 17/11/2021 |
Trillium Therapeutics, Inc. /Old/
 Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Direttore Finanziario/CFO | 06/06/2014 |
| PROMIS NEUROSCIENCES, INC. | Direttore Finanziario/CFO | 20/10/2010 |
| APTOSE BIOSCIENCES INC. | Direttore Finanziario/CFO | 01/01/2003 |
| TIMMINCO LIMITED | Comptroller/Controller/Auditor | 01/01/2000 |
Formazione di James Parsons
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
58
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Timminco Ltd.
 Timminco Ltd. Metal FabricationProducer Manufacturing Manufactures specialty magnesium, calcium and strontium alloys | Producer Manufacturing |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
